Life Sciences Partners and the Erasmus MC Biomedical Fund have co-led a series-A funding round for Skyline Diagnostics BV. No financial details have been disclosed. The new capital will enable the company to bring its first product, the Acute myeloid leukemia Biochip, to market.
Polish buyout firm Abris Capital Partners has signed an agreement to sell its stake in Polish locomotive lessor Cargounit, also known as Industrial Division, to Three Seas Investment Fund (3SIIF).
Amplify IV targets seed and series-A rounds, while Amplify Select makes follow-on investments in existing portfolio companies
GP had previously made an offer of SEK 70 per share, which was later increased to SEK 72 per share
Company intends to boost its production capability, bolster its international expansion and pursue a buy-and-build strategy